Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.

Autor: Phelan R; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. rphelan@mcw.edu.; Division of Pediatric Hematology/Oncology/Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA. rphelan@mcw.edu., Im A; University of Pittsburgh/UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Hunter RL; Division of Hematology, University of Colorado Anschutz Medical Center, Aurora, CO, USA., Inamoto Y; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Lupo-Stanghellini MT; Hematology and Bone Marrow Transplantation Unit, IRCC San Raffaele Scientific Institute, Milano, Italy., Rovo A; Department of Hematology and Central Hematology Laboratory, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland., Badawy SM; Division of Hematology, Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Burns L; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Eissa H; Department of Pediatrics, Center for Cancer and Blood Disorders, University of Colorado School of Medicine, Aurora, CO, USA., Murthy HS; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA., Prasad P; Louisiana State University Health Sciences Center/Children's Hospital of New Orleans, Department of Pediatrics, New Orleans, LA, USA., Sharma A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA., Suelzer E; Medical College of Wisconsin, Milwaukee, WI, USA., Agrawal V; Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Aljurf M; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia., Baker K; Duke University Medical Center, Durham, NC, USA., Basak GW; University Clinical Centre, Medical University of Warsaw, Warsaw, Poland., Buchbinder D; Division of Pediatric Hematology, Children's Hospital of Orange County, Orange, CA, USA., DeFilipp Z; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA, USA., Grkovic LD; University Hospital Centre Zagreb, Zagreb, Croatia., Dias A; Beth Israel Deaconess Medical Center, Boston, MA, USA., Einsele H; Universitätsklinikum Würzburg, Department of Internal Medicine II, Würzburg, Germany., Eisenberg ML; Department of Urology, Stanford University School of Medicine, Stanford, CA, USA., Epperla N; Division of Hematology, Department of Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA., Farhadfar N; Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, FL, USA., Flatau A; Association of Cancer Online Resources, Association of Cancer Online Resources, Austin, TX, USA., Gale RP; Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK., Greinix H; Medical University Graz, Division of Hematology, Graz, Austria., Hamilton BK; Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA., Hashmi S; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.; Department of Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, UAE., Hematti P; Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin, Madison, WI, USA., Jamani K; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Maharaj D; South Florida Bone Marrow Stem Cell Transplant Institute, Boynton Beach, FL, USA., Murray J; The Christie NHS Foundation Trust, Manchester, UK., Naik S; Division Hematology and Oncology, Department of Medicine, Penn State Cancer Institute, Milton Hershey Medical Center, Hershey, PA, USA., Nathan S; Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, IL, USA., Pavletic S; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Peric Z; University Hospital Centre Zagreb and Medical School University of Zagreb, Zagreb, Croatia., Pulanic D; University Hospital Centre Zagreb and Medical School University of Zagreb, Zagreb, Croatia., Ross R; The University of Sheffield, Sheffield, UK., Salonia A; University Vita-Salute San Raffaele, Milan, Italy.; Division of Experimental Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milan, Italy., Sanchez-Ortega I; Institut Catala d'Oncologia, Barcelona, Spain., Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Schechter T; Division of Pediatric Hematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada., Shah AJ; Division of Hematology/ Oncology/ Stem Cell Transplantation and Regenerative Medicine, Lucile Packard Children's Hospital, Stanford School of Medicine, Palo Alto, CA, USA., Smith SM; Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA., Snowden JA; The University of Sheffield, Sheffield, UK.; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Steinberg A; Westchester Medical Center, Valhalla, NY, USA., Tremblay D; Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Vij SC; Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Walker L; Department of Oncology, Tom Baker Cancer Centre, Calgary, AB, Canada., Wolff D; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Yared JA; Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA., Schoemans H; Department of Hematology, University Hospitals Leuven, Leuven, Belgium.; Department of Public Health and Primary Care, ACCENT VV, KU Leuven - University of Leuven, Leuven, Belgium., Tichelli A; University Hospital Basel, Basel, Switzerland.
Jazyk: angličtina
Zdroj: Bone marrow transplantation [Bone Marrow Transplant] 2022 Jul; Vol. 57 (7), pp. 1150-1163. Date of Electronic Publication: 2022 May 06.
DOI: 10.1038/s41409-022-01591-z
Abstrakt: Male-specific late effects after hematopoietic cell transplantation (HCT) include genital chronic graft-versus-host disease (GvHD), hypogonadism, sexual dysfunction, infertility, and subsequent malignancies. They may be closely intertwined and cause prolonged morbidity and decreased quality of life after HCT. We provide a systematic review of male-specific late effects in a collaboration between transplant physicians, endocrinologists, urologists, dermatologists, and sexual health professionals through the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research, and the Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. The systematic review summarizes incidence, risk factors, screening, prevention and treatment of these complications and provides consensus evidence-based recommendations for clinical practice and future research.
(© 2022. The Author(s).)
Databáze: MEDLINE
Externí odkaz: